Abstract
Renal failure is a common problem in patients suffering from trauma, burn injury, sepsis, or shock of any other cause. Impaired renal function may supervene on these conditions in a way that causes the patient’s condition to further deteriorate. In the acute state of renal failure, defined as a potentially reversible failure in originally normal unobstructed kidneys, the mortality rate improved from 90% to some 50% after the introduction of hemodialysis 40–50 years ago [1]. In the subsequent years, mortality has not improved further. One cause for this may be that the population of patients being treated today is a group at higher risk with more complicated conditions than 40 years ago. In multiorgan failure, mortality increases in proportion to the number of organs that are involved. The mortality rate is 8% when only the kidneys are failing [1] and increases up to 100% when three or more organs are involved [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Cameron JS (1986) Acute renal failure in the intensive care unit today. Intensive Care Med 12:64–70
Fry DE, Garrison RN, Heitsch RC, Calhoun K, Polk HC Jr (1980) Determinants of death in patients with intra-abdominal abscess. Surgery 88:517–523
Better OS, Rubinstein I, Winaver J (1992) Recent insights into the pathogenesis and early management of the crush syndrome. Semin Nephrol 12:217–222
Sandin R (1993) Kidney function in shock. Acta Anaesthesiol Scand 37 Suppl 98:14–19
Ofstad J, Aukland K (1985) Renal circulation. In: Seldin DW, Giebisch G (eds) The kidney: physiology and pathophysiology. Raven, New York, pp 471–496
Steinhausen M, Endlich K, Wiegman DL (1990) Glomerular blood flow. Kidney Int 38:769–784
Stein JH (1990) Regulation of the renal circulation. Kidney Int 38:571–576
Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572
Oliver JA, Sciacca RR, Pinto J, Cannon PJ (1981) Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J Clin Invest 67:229–237
Fink MP, MacVittie TJ, Casey LC (1984) Effects of nonsteroidal anti-inflammatory drugs on renal function in septic dogs. J Surg Res 36:516–525
Conger JD, Burke TJ (1976) Effects of anesthetic agents on autoregulation of renal hemodynamics in the rat and dog. Am J Physiol 230:652–657
Zager RA (1991) Adenine nucleotide changes in kidney, liver, and small intestine during different forms of ischemic injury. Circ Res 68:185–196
Yu L, Seguro AC, Rocha AS (1992) Acute renal failure following hemorrhagic shock: protective and aggravating factors. Renal Failure 14:49–55
Weaver LC (1977) Cardiopulmonary sympathetic afferent influences on renal nerve activity. Am J Physiol 233:H592–H599
Thames MD, Abboud FM (1979) Reflex inhibition of renal sympathetic nerve activity during myocardial ischemia mediated by left ventricular receptors with vagal afférents in dogs. J Clin Invest 63:395–402
Parekh N, Veith U (1981) Renal hemodynamics and oxygen consumption during postischemic acute renal failure in the rat. Kidney Int 19:306–316
Baumgärtl H, Leichtweiss HP, Lubbers DW, Weiss C, Huland H (1972) The oxygen supply of the dog kidney: measurements of intrarenal pO2. Microvasc Res 4:247–257
Hollenberg NK, Epstein M, Rosen SM, Basch RI, Oken DE, Merrill JP (1968) Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) 47:455–474
Vetterlein F, Pethö A, Schmidt G (1986) Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am J Physiol 251:H510–H519
Palier MS, Hoidal JR, Ferris TF (1984) Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74:1156–1164
Bayati A, Fròdin L, Källskog Ö, Hellberg O, Wolgast M (1985) Prevention of acute renal failure by long term treatment with alopurinol. Acta Physiol Scand 124 Suppl 542:383
Hansson R, Johanson S, Jonsson O, Petterson S, Schersten T, Waldenstrom J (1986) Kidney protection by pretreatment with free radical scavengers and allopurinol: renal function at recirculation after warm ischemia in rabbits. Clin Sci 71:245–251
Van Lambalgen AA, van Kraats AA, van den Bos GC et al. (1993) Development of renal failure in endotoxemic rats: can it be explained by early changes in renal energy metabolism? Nephron 65:88–94
Hollenberg NK, Adams DF, Oken DE, Abrams HL, Merrill JP (1970) Acute renal failure due to nephrotoxins. Renal hemodynamic and angiographic studies in man. N Engl J Med 282:1329–1334
Zager RA (1988) Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion. Am J Physiol 254:F574–F581
Spiegel DM, Shanley PF, Molitoris BA (1990) Mild ischemia predisposes the S3 segment to gentamicin toxicity. Kidney Int 38:459–464
Zager RA (1992) Gentamicin effects on renal ischemia/reperfusion injury. Circ Res 70:20–28
Zager RA (1991) Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock. Kidney Int 39:111–119
Fraley DS, Adler S (1977) Correction of hyperkalemia by bicarbonate despite constant blood pH. Kidney Int 12:354–360
Humes DH (1986) Role of calcium in pathogenesis of acute renal failure. Am J Physiol 250:F579–F589
Goldfarb D, Iaina A, Serban I, Gavendo S, Kapuler S, Eliahou HE (1983) Beneficial effects of verapamil in ischemic acute renal failure in the rat. Proc Soc Exp Biol Med 172:389–392
Malis CD, Cheung JY, Leaf A, Bonventre JV (1983) Effects of verapamil in models of ischemic acute renal failure in the rat. Am J Physiol 245:F735–F742
Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, Schrier RW (1984) Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. J Clin Invest 74:1830–1841
Chintala MS, Jandhyala BS (1990) Renal failure in haemorrhagic shock in dogs: salutary effects of the calcium entry blocker felodipine. Naunyn Schmiedebergs Arch Pharmacol 341:357–363
Sandin R, Feuk U, Wahlberg J, Modig J (1991) Effects of diltiazem on postischemic renal cortical microcirculation in the pig. Acta Anaesthesiol Scand 35:424–429
Conger JD, Robinette JB, Guggenheim SJ (1981) Effect of acetylcholine on the early phase of reversible norepinephrine-induced acute renal failure. Kidney Int 19:399–409
Eliahou HE, Brodman RR, Friedman EA (1973) Adrenergic blockers in ischemic acute renal failure in the rat. In: Friedman EA, Eliahou HE (eds) Proceedings of the conference on acute renal failure. National Institute of Health, New York, pp 265–280 (DHEW publication no (NIH) 74-608)
Russell JD, Churchill DN (1989) Calcium antagonists and acute renal failure. Am J Med 87:306–315
Caroli GC, Snyder JV (1982) Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 243:R131–R141
Schaer GL, Fink MP, Chernow B, Ahmed S, Parrillo JE (1990) Renal hemodynamics and prostaglandin E2 excretion in a nonhuman primate model of septic shock. Crit Care Med 18:52–59
Cumming AD, Kline R, Linton AL (1988) Association between renal and sympathetic responses to nonhypotensive systemic sepsis. Crit Care Med 16:1132–1137
Sandok EK, Lerman A, Stingo AJ, Perrella MA, Gloviczki P, Burnett JC Jr (1992) Endothelin in a model of acute ischemic renal dysfunction: modulating action of atrial natriuretic factor. J Am Soc Nephrol 3:196–202
Henrich WL, Hamasaki Y, Said SI, Campbell WB, Cronin RE (1982) Dissociation of systemic and renal effects in endotoxinemia. Prostaglandin inhibition uncovers an important role of renal nerves. J Clin Invest 69:691–699
Badr KF, Kelley VE, Rennke HG, Brenner BM (1986) Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 30:474–480
Linas SL, Whittenburg D, Repine JE (1991) Role of neutrophil derived oxidants and elastase in lipopolysaccharide-mediated renal injury. Kidney Int 39:618–623
Marietta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS (1988) Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706–8711
Shultz PJ, Tayeh MA, Marietta MA, Raij L (1991) Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 261:F600–F606
Radomski MW, Palmer RMJ, Moncada S (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482–1489
Shultz PJ, Raij L (1992) Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90:1718–1725
Schrier RW, Burke TJ (1994) New aspects in pathogenesis of acute renal failure. Nephrol Dial Transplant 9 Suppl 4:9–14
Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ (1993) Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 142:59–70
Hekman CM, Loskutoff DJ (1988) Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. Arch Biochem Biophys 262:199–210
Bloom ITM, Bentley FR, Wilson MA, Garrison RN (1993) In vivo effects of endothelin on the renal microcirculation. J Surg Res 54:274–280
Masaki T, Kimura S, Yanagisawa M, Goto K (1991) Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84:1457–1468
Kon V, Badr KF (1991) Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40:1–12
Stingo AJ, Clavell AL, Aarhus LL, Burnett JC Jr (1993) Biological role for the endothelin-A receptor in aortic cross-clamping. Hypertension 22:62–66
Firth JD, Ratcliffe PJ (1992) Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest 90:1023–1031
Wilmore DW, Dudrick SJ (1969) Treatment of acute renal failure with intravenous essential L-amino acids. Arch Surg 99:669–673
Abel RM, Beck Ch Jr, Abbott WM, Ryan JA Jr, Barnett GO, Fischer JE (1973) Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. N Engl J Med 288:695–699
Feinstein EI, Blumenkrantz MJ, Healy M et al. (1981) Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine (Baltimore) 60:124–137
Graziani G, Casati S, Cantaluppi A (1982) Dopamine-furosemide therapy in acute renal failure. Proc Eur Dial Transplant Assoc 19:319–325
Lumlertgul D, Keoplung M, Sitprija V, Moollaor P, Suwangool P (1989) Furosemide and dopamine in malarial acute renal failure. Nephron 52:40–44
Baldwin L, Henderson A, Hickman P (1994) Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120:744–747
Thompson BT, Cockrill BA (1994) Renal-dose dopamine: a siren song? Lancet 344:7–8
Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D (1972) Uremic and non-uremic complications in acute renal failure: evaluation of early and frequent dialysis on prognosis. Kidney Int 1:190–196
Cahill CJ (1983) Prevention of postoperative renal failure in patients with obstructive jaundice — the role of bile salts. Br J Surg 70:590–595
Brezis M, Epstein FH (1989) A closer look at radiocontrast-induced nephropathy. N Engl J Med 320:179–181
Schafferhans K, Heidbreder E, Grimm D, Heidland A (1986) Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron 44:240–244
Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A (1987) Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 80:1232–1237
Rahman SN, Kim GE, Mathew AS et al. (1994) Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45:1731–1738
Conger JD, Falk SA, Yuan BH, Schrier RW (1989) Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35:1126–1132
Roy DR (1986) Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 251:F220–F225
Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW (1991) Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 2:1130–1135
Mehls O, Tönshoff B, Blum WF, Heinrich U, Seidel C (1990) Growth hormone and insulinlike growth factor 1 in chronic renal failure — pathophysiology and rationale for growth hormone treatment. Acta Pædiatr Scand Suppl 370:28–34
Thomas FM, Knowles SE, Owens PC et al. (1991) Effects of full-length and truncated insulinlike growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. J Endocrinol 128:97–105
Pillion DJ, Haskell JF, Meezan E (1988) Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules. Am J Physiol 255:E504–E512
Hirschberg R, Brunori G, Kopple JD, Guler HP (1993) Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43:387–397
Ding HU, Kopple JD, Cohen A, Hirschberg R (1993) Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281–2287
O’Shea MH, Layish DT (1992) Growth hormone and the kidney: a case presentation and review of the literature. J Am Soc Nephrol 3:157–161
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jenssen, T.G. (1996). Renal Failure in the Acute Catabolic State. In: Revhaug, A. (eds) Acute Catabolic State. Update in Intensive Care and Emergency Medicine, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48801-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-48801-6_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-48803-0
Online ISBN: 978-3-642-48801-6
eBook Packages: Springer Book Archive